成人吉兰-巴雷综合征神经预后判断指南
该指南采用GRADE方法完成叙述性系统评价,纳入45篇符合标准文献,评估8个候选临床变量和6个预测模型对成人GBS神经预后的可靠性。推荐球部无力(疾病谷期肌力减弱程度)和Erasmus GBS呼吸功能不全评分对机械通气需求为中等可靠预测;Erasmus GBS结局评分(EGOS)及改良EGOS对3个月及以后独立行走为中等可靠预测。良好实践建议包括预后判断时兼顾急性期与恢复期、咨询时讨论可能的机械通气与肠内营养需求、以及综合整体临床情况而非单一变量。指南指出仅少数预测因素被判定为中等可靠,需要更高质量数据。
要点
- 推荐球部无力(疾病谷期肌力减弱程度)对机械通气需求为中等可靠预测因素。
- 推荐Erasmus GBS呼吸功能不全评分对机械通气需求为中等可靠预测因素。
- EGOS及改良EGOS被认定为3个月及以后独立行走的中等可靠预测因素。
- 良好实践建议:预后判断应兼顾疾病急性期与恢复期,咨询时讨论机械通气与肠内营养可能性。
- 良好实践建议:预后判断应考虑完整临床情况,而非单一变量。
适用人群与场景
- 成人吉兰-巴雷综合征(GBS)患者,用于向患者和/或代理人咨询时进行神经预后判断。
- 成人GBS患者中10-30%在疾病急性期需要机械通气。
处置流程与药物剂量
- 良好实践建议:预后判断时考虑疾病的急性期和恢复期两个阶段。
- 良好实践建议:咨询时讨论急性期可能需要机械通气以及肠内营养。
- 良好实践建议:预后判断时考虑完整临床情况,而非单一变量。
研究设计与关键结果
- 采用GRADE方法完成叙述性系统评价,共45篇文章符合纳入标准以指导推荐。
- 共评估8个候选临床变量和6个预测模型。
- 推荐球部无力(疾病谷期肌力减弱程度)对机械通气需求为中等可靠预测。
- 推荐Erasmus GBS呼吸功能不全评分对机械通气需求为中等可靠预测。
- EGOS和改良EGOS被认定为3个月及以后独立行走的中等可靠预测因素。
证据类型、等级与局限
- 证据类型:指南,采用GRADE方法进行叙述性系统评价。
- 推荐基于四项GRADE标准:证据质量、利弊平衡、价值观与偏好、资源利用。
- 局限:原文报告基于现有证据仅少数预测因素被判定为中等可靠,需要更高质量数据。
对床旁实践的改变
- 对成人GBS患者咨询时,可依据球部无力(疾病谷期肌力减弱程度)和Erasmus GBS呼吸功能不全评分预测机械通气需求(中等可靠)。
- 对成人GBS患者咨询时,可依据EGOS和改良EGOS预测3个月及以后独立行走能力(中等可靠)。
- 良好实践建议:预后判断应兼顾急性期与恢复期,咨询时讨论机械通气与肠内营养需求,综合考虑完整临床情况。
指南或共识出处
- 指南名称:Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome(成人吉兰-巴雷综合征神经预后判断指南),发表于Neurocrit Care。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Guillain-Barré syndrome (GBS) often carries a favorable prognosis. Of adult patients with GBS, 10-30% require mechanical ventilation during the acute phase of the disease. After the acute phase, the focus shifts to restoration of motor strength, ambulation, and neurological function, with variable speed and degree of recovery. The objective of these guidelines is to provide recommendations on the reliability of select clinical predictors that serve as the basis of neuroprognostication and provide guidance to clinicians counseling adult patients with GBS and/or their surrogates.
METHODS: A narrative systematic review was completed using Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Candidate predictors, including clinical variables and prediction models, were selected based on clinical relevance and presence of appropriate body of evidence. The Population/Intervention/Comparator/Outcome/Time frame/Setting (PICOTS) question was framed as follows: "When counseling patients or surrogates of critically ill patients with Guillain-Barré syndrome, should [predictor, with time of assessment if appropriate] be considered a reliable predictor of [outcome, with time frame of assessment]?" Additional full-text screening criteria were used to exclude small and lower quality studies. Following construction of an evidence profile and summary of findings, recommendations were based on four GRADE criteria: quality of evidence, balance of desirable and undesirable consequences, values and preferences, and resource use. In addition, good practice recommendations addressed essential principles of neuroprognostication that could not be framed in PICOTS format.
RESULTS: Eight candidate clinical variables and six prediction models were selected. A total of 45 articles met our eligibility criteria to guide recommendations. We recommend bulbar weakness (the degree of motor weakness at disease nadir) and the Erasmus GBS Respiratory Insufficiency Score as moderately reliable for prediction of the need for mechanical ventilation. The Erasmus GBS Outcome Score (EGOS) and modified EGOS were identified as moderately reliable predictors of independent ambulation at 3 months and beyond. Good practice recommendations include consideration of both acute and recovery phases of the disease during prognostication, discussion of the possible need for mechanical ventilation and enteral nutrition during counseling, and consideration of the complete clinical condition as opposed to a single variable during prognostication.
CONCLUSIONS: These guidelines provide recommendations on the reliability of predictors of the need for mechanical ventilation, poor functional outcome, and independent ambulation following GBS in the context of counseling patients and/or surrogates and suggest broad principles of neuroprognostication. Few predictors were considered moderately reliable based on the available body of evidence, and higher quality data are needed.
参考来源
- Busl KM, Fried H, Muehlschlegel S, et al. Guidelines for Neuroprognostication in Adults with Guillain-Barré Syndrome. Neurocrit Care. 2023. PMID: 36964442. doi:10.1007/s12028-023-01707-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。